Atlas Venture Fund XII, L.P.

Insider profile

Atlas Venture Fund XII, L.P.'s trades of Disc Medicine Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2025-12-17 2025-12-17 PrS Proposed sale
5,694
239.75
US$336,452
5,694 239.75 US$336,452
2025-12-16 2025-12-16 PrS Proposed sale
62,637
491.35
US$1,048,263
62,637 491.35 US$1,048,263
2025-12-15 2025-12-15 PrS Proposed sale
81,519
88.39
US$3,707,834
81,519 88.39 US$3,707,834
2025-12-12 2025-12-12 PrS Proposed sale
9,481
93.60
US$887,422
9,481 93.60 US$887,422
2025-06-25 2025-06-25 PrS Proposed sale
28,977
10.48
US$303,679
28,977 10.48 US$303,679
2025-06-24 2025-06-24 PrS Proposed sale
16,132
9.87
US$159,223
16,132 9.87 US$159,223
2025-05-06 2025-05-06 PrS Proposed sale
5,883
11.50
US$67,654
5,883 11.50 US$67,654
2022-01-11 2022-01-11 B Purchase
535,000 +12.5%
14.00
US$7,490,000
535,000 +12.5% 14.00 US$7,490,000